Continuous Treatment Effects with Surrogate Outcomes
0
Sign in to get full access
Overview
- This research paper proposes a new method for estimating continuous treatment effects using surrogate outcomes.
- The method aims to improve the efficiency of treatment effect estimation when the primary outcome is difficult or expensive to measure.
- The paper provides a formal statistical framework, estimation procedures, and theoretical guarantees for the proposed approach.
Plain English Explanation
The paper focuses on a common challenge in medical and social science research: estimating the impact of a treatment or intervention when the desired outcome is hard to directly measure. For example, a new drug may aim to improve a patient's long-term health, but directly measuring that health outcome could be difficult or take a long time.
To address this, the researchers suggest using a surrogate outcome - a more easily measured outcome that is believed to be related to the true outcome of interest. By modeling the relationship between the surrogate and true outcomes, the researchers show they can still obtain reliable estimates of the treatment's impact, even when the true outcome is not directly observed.
Their approach allows for continuous treatments, meaning the level of treatment can vary across individuals, rather than just being "treated" or "not treated." This is often more realistic than a simple binary treatment in many real-world scenarios.
The paper provides a formal statistical framework for this continuous treatment effect estimation problem using surrogates. It proposes new estimation methods and proves that under certain assumptions, these methods can accurately estimate the treatment effects, even when the true outcome is unobserved. This can lead to more efficient estimation of treatment impacts compared to traditional approaches.
Technical Explanation
The paper considers a setting where each individual has a continuous treatment level (e.g., drug dosage) and two outcomes: a surrogate outcome that is easier to measure, and a primary outcome that is more difficult or expensive to obtain.
The key idea is to model the relationship between the surrogate and primary outcomes using a flexible regression framework. This allows the researchers to leverage the observed surrogate outcomes to infer the unobserved primary outcomes and estimate the treatment's impact on the primary outcome of interest.
The paper develops new estimation procedures based on this modeling approach and provides theoretical guarantees showing that under certain assumptions, these methods can accurately estimate the continuous treatment effects, even when the primary outcome is not fully observed.
This builds on prior work on causal inference with surrogate outcomes and continuous treatment effects, extending the methodology to handle the combined challenge of continuous treatments and unobserved primary outcomes.
Critical Analysis
The paper makes some strong assumptions, such as the existence of a well-specified regression model linking the surrogate and primary outcomes. In practice, correctly specifying this model may be challenging, and model misspecification could lead to biased treatment effect estimates.
Additionally, the paper does not address the issue of hidden confounders that may affect both the treatment assignment and the outcomes. Failure to account for such confounding factors could also undermine the validity of the causal inference.
Further research could explore more robust estimation methods that are less sensitive to model assumptions, as well as techniques for causal discovery to better understand the underlying causal relationships between the variables.
Conclusion
This research paper presents a novel statistical framework for estimating continuous treatment effects using surrogate outcomes. By modeling the relationship between the surrogate and primary outcomes, the proposed methods can provide efficient estimates of treatment impacts, even when the primary outcome is difficult or expensive to measure directly.
While the paper makes strong assumptions and does not address all potential sources of bias, it represents an important step forward in improving the practicality and cost-effectiveness of causal inference in real-world settings where direct measurement of the outcome of interest is challenging.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
0
Continuous Treatment Effects with Surrogate Outcomes
Zhenghao Zeng, David Arbour, Avi Feller, Raghavendra Addanki, Ryan Rossi, Ritwik Sinha, Edward H. Kennedy
In many real-world causal inference applications, the primary outcomes (labels) are often partially missing, especially if they are expensive or difficult to collect. If the missingness depends on covariates (i.e., missingness is not completely at random), analyses based on fully observed samples alone may be biased. Incorporating surrogates, which are fully observed post-treatment variables related to the primary outcome, can improve estimation in this case. In this paper, we study the role of surrogates in estimating continuous treatment effects and propose a doubly robust method to efficiently incorporate surrogates in the analysis, which uses both labeled and unlabeled data and does not suffer from the above selection bias problem. Importantly, we establish the asymptotic normality of the proposed estimator and show possible improvements on the variance compared with methods that solely use labeled data. Extensive simulations show our methods enjoy appealing empirical performance.
Read more5/24/2024
📊
0
On the role of surrogates in the efficient estimation of treatment effects with limited outcome data
Nathan Kallus, Xiaojie Mao
In many experimental and observational studies, the outcome of interest is often difficult or expensive to observe, reducing effective sample sizes for estimating average treatment effects (ATEs) even when identifiable. We study how incorporating data on units for which only surrogate outcomes not of primary interest are observed can increase the precision of ATE estimation. We refrain from imposing stringent surrogacy conditions, which permit surrogates as perfect replacements for the target outcome. Instead, we supplement the available, albeit limited, observations of the target outcome with abundant observations of surrogate outcomes, without any assumptions beyond unconfounded treatment assignment and missingness and corresponding overlap conditions. To quantify the potential gains, we derive the difference in efficiency bounds on ATE estimation with and without surrogates, both when an overwhelming or comparable number of units have missing outcomes. We develop robust ATE estimation and inference methods that realize these efficiency gains. We empirically demonstrate the gains by studying long-term-earning effects of job training.
Read more9/4/2024
🔮
0
Conformal Prediction for Causal Effects of Continuous Treatments
Maresa Schroder, Dennis Frauen, Jonas Schweisthal, Konstantin He{ss}, Valentyn Melnychuk, Stefan Feuerriegel
Uncertainty quantification of causal effects is crucial for safety-critical applications such as personalized medicine. A powerful approach for this is conformal prediction, which has several practical benefits due to model-agnostic finite-sample guarantees. Yet, existing methods for conformal prediction of causal effects are limited to binary/discrete treatments and make highly restrictive assumptions such as known propensity scores. In this work, we provide a novel conformal prediction method for potential outcomes of continuous treatments. We account for the additional uncertainty introduced through propensity estimation so that our conformal prediction intervals are valid even if the propensity score is unknown. Our contributions are three-fold: (1) We derive finite-sample prediction intervals for potential outcomes of continuous treatments. (2) We provide an algorithm for calculating the derived intervals. (3) We demonstrate the effectiveness of the conformal prediction intervals in experiments on synthetic and real-world datasets. To the best of our knowledge, we are the first to propose conformal prediction for continuous treatments when the propensity score is unknown and must be estimated from data.
Read more7/4/2024
0
Doubly Robust Inference in Causal Latent Factor Models
Alberto Abadie, Anish Agarwal, Raaz Dwivedi, Abhin Shah
This article introduces a new estimator of average treatment effects under unobserved confounding in modern data-rich environments featuring large numbers of units and outcomes. The proposed estimator is doubly robust, combining outcome imputation, inverse probability weighting, and a novel cross-fitting procedure for matrix completion. We derive finite-sample and asymptotic guarantees, and show that the error of the new estimator converges to a mean-zero Gaussian distribution at a parametric rate. Simulation results demonstrate the practical relevance of the formal properties of the estimators analyzed in this article.
Read more4/16/2024